Injecting NOVAREL^®

At Ferring, we understand that having to mix and administer your own medication can be an intimidating procedure, so we want to make it as easy for you as possible.

NOVAREL^® is approved for intramuscular (IM) injection. To help you administer NOVAREL^®, we've developed easy-to-follow instruction guides. Simply access the instructions below.

If you have any questions or concerns regarding your injections, don't hesitate to contact your doctor's office.

NOVAREL^® is indicated for induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with urofollitropins or human menotropins.

Important Safety Information

NOVAREL^® should be used in conjunction with urofollitropin or human menopausal gonadotropins only by physicians thoroughly experienced with infertility treatment. Principal serious adverse reactions are: OHSS; enlargement or rupture of ovarian cysts with resultant hemoperitoneum; multiple births; and arterial thromboembolism. NOVAREL^® is contraindicated in women with precocious puberty, androgen-dependent neoplasm, and prior allergic reaction to HCG. HCG may cause fetal harm when administered to a pregnant woman. Combined HCG/PMS (pregnant mare’s serum) therapy has been noted to induce high incidences of external congenital anomalies in the offspring of mice, in a dose-dependent manner. The potential extrapolation to humans has not been determined.

Click here to see Full Prescribing Information for NOVAREL^®.

Previous: Using NOVAREL®

Next: NOVAREL® FAQs